Spatial and single-cell characterization of human glioblastoma tumor microenvironment reveals malignant cellular communities
Mapping glioblastoma's internal structure reveals how tumor cells hide from the immune system, suggesting new targets for combination treatments.
This large-scale spatial multi-omics study of 100 GBM patients defines four spatially organized malignant cellular communities and characterizes their intercellular communication networks, revealing potential therapeutic targets including MES-Hyp and MES-Ast subpopulations. Published in Nature Neuroscience, this represents the most comprehensive spatial characterization of GBM to date.
What the study was
- Study design
- Multi-modal spatial transcriptomics + single-cell RNA-seq + scATAC-seq + patch-seq (n=100 GBM patients, 121 spatial profiles)
- Population
- Primary glioblastoma (GBM) patients
- Sample size
- 100
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Nature neuroscience
Why it surfaced
Large-scale, high-quality multi-omics GBM study in Nature Neuroscience; strong science but no direct clinical implementation; preclinical therapeutic targets require validation.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.